Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Clinical Laboratory Improvement Amendments Establish Quality Standards for Lab Tests

Staff  |  Issue: April 2014  |  April 2, 2014

Personnel requirements tie into the complexity of testing. The condition differs for personnel who execute moderate- and high-complexity testing and are identified individually. Define qualifications for a precise mixture of positions and accountability.

All laboratories must have one of the below CLIA certifications to perform clinical testing on specimens:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Certificate of Waiver is issued to a laboratory to perform waived tests only.
  • Certificate of Provider-Performed Microscopy Procedures is issued to a laboratory in which a mid-level practitioner, physician or dentist can perform microscopy procedures. Waived tests may also be performed.
  • Certificate of Registration is issued to a laboratory that performs moderate and/or high complexity testing until it is determined by a survey to be in compliance with CLIA regulations.
  • Certificate of Compliance is issued to a laboratory after an inspection determines that it is compliant with CLIA requirements.
  • Certificate of Accreditation is issued to a laboratory on the basis of the accreditation of an organization approved by CMS.

Once the certification(s) is obtained, the physicians should evaluate which laboratory tests are covered. Medicare noncovered services should be accompanied by an Advanced Beneficiary Notice (ABN). If a physician has unassigned claims, the beneficiary or their representative must agree to be financially responsible for the noncovered services by applying their signature in the appropriate section. This ensures the physician services will be compensated by the beneficiary receiving the services. Assigned claims do not require a signature from the beneficiary or their representative; the physician can simply have a witness sign the form documenting the beneficiary’s refusal, and ABN will be effective.

ABNs are not required for such services as screening tests, cosmetic surgery and routine physicals. Nevertheless, physicians should be cautious in determining when to use an ABN, because some of the excluded categories could be covered under other circumstances. For example, when screenings, such as mammography, may prove unclear about whether it’s covered under Medicare, it’s better to acquire an ABN.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

How to Apply for a CLIA Certificate of Waiver

Apply for a Certificate of Waiver via form CMS-116, which can be obtained on the CMS website at http://www.cms.gov/clia/cliaapp.asp or from your state health department. The application requests the following information to be complete:

  • General Information—Provide information about your organization, including street address, name of director and federal tax identification number. Don’t fill out the CLIA identification number if this is an initial application.
  • Type of Certificate Requested—Request a Certificate of Waiver.
  • Type of Laboratory—Indicate the facility or setting in which you will perform the rapid test (e.g., community clinic, health fair, mobile laboratory [van]). If none of the categories applies to your setting, check “other.”
  • Hours of Laboratory Testing—Indicate the times you plan to do testing.
  • Multiple Sites—Indicate if you will be doing testing at more than one site. If you will have multiple sites, provide the number of sites and complete the remainder of this section. In general, a mobile van is considered a multiple site if it is not in a fixed location and moves from site to site for testing. The name and address of the testing site for that van would be the same as the organization it operates under or the physical location where the van is housed.
  • Waived Testing—Estimate the number of tests you will be performing annually.
  • Non-Waived Tests—Skip this section if you are performing a waived test only.
  • Type of Control—Check the type of organization for which you are making this application—private nonprofit, for-profit, government).
  • Director Affiliation with Other Laboratories—Provide the name and address of other laboratories that your director also directs. CLIA regulations allow a director to direct a maximum of five laboratories.
  • Individuals Involved in Laboratory Testing—Indicate the total number of individuals who are directing, supervising, consulting or testing. Include counselors only if they will perform or supervise testing.
  • Consent & Signature—Carefully read the consent information at the bottom of p. 4 before signing and dating.

The Certificate of Waiver application should be forwarded to the address of the local state agency in which the testing will be performed. CMS has a list of these agencies at http://cms.hhs.gov/clia/ssa-map.asp. You can also contact your state agency for assistance in filling out the application. You will need to submit a fee of $150 with the application.

Page: 1 2 3 | Single Page
Share: 

Filed under:Billing/CodingFrom the CollegeLegislation & AdvocacyPractice SupportProfessional TopicsQuality Assurance/Improvement Tagged with:AC&RAmerican College of Rheumatology (ACR)BillingCodinglabsLegislationMedicarePractice Managementrheumatologist

Related Articles

    Be Aware of New Waived Tests

    July 1, 2007

    Keeping current on changes to laboratory certifications for common lab tests can save your practice time—and money. Since the passage of the Clinical Laboratory Improvement Amendments (CLIA) in 1988, all health-assessment laboratory tests are ranked for complexity, and their complexity dictates which labs can process Centers for Medicare and Medicaid Services (CMS)–reimbursed tests. In accordance with CLIA, each laboratory facility must register with CMS to receive a CLIA certification. There are five certifications, each with differing degrees of complexity, listed from least to most complex: Certificate of Waiver, Certificate of Provider-Performed Microscopy Procedures, Certificate of Registration, Certificate of Compliance, and the Certificate of Accreditation.

    Serological Antibody Tests in COVID-19: Test Reliability and Utility

    June 10, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    Corona Borealis Studio / shutterstock.com

    The Reliability & Utility of Serological Antibody Tests in COVID-19

    September 11, 2020

    Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies may play a critical role in the management of the worldwide health crisis. Such testing may reveal key information for epidemiology, convalescent plasma therapies and vaccine development. However, the situation is complex, and much is unknown. Although such testing may ultimately be used to…

    How to Create a Safe Practice & Prep for a COVID-19 Resurgence

    August 12, 2020

    For many months, the healthcare world has been significantly affected by the swift and per­vasive effects of SARS-CoV-2, which causes COVID-19. The virus has severely affected the delivery of patient care by all providers, including those in hospitals and emergency care settings, who grappled with the response to massive influxes of COVID-19 patients, and those…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences